Lucy Coassin

Lucy Coassin is a seasoned professional in the field of business development and partnerships within the healthcare and biotechnology sectors. Currently serving as Principal at Northpond Ventures since March 2023, Lucy previously held senior roles including Senior Director of Pharma Partnerships at Current Health, where the focus was on enhancing clinical trials through remote patient monitoring. Experience also encompasses serving as Director of Business Development at Science 37, a leader in decentralized clinical trials, and at Farcast Biosciences, where revolutionary technology aimed to improve cancer treatment pathways. Educational credentials include an MBA from Stanford University and a BS in Chemistry from Duke University.